MORRISVILLE, N.C., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company has entered into a Common Stock Purchase Agreement (the ...

MORRISVILLE, N.C., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Compensation Committee of Novan’s Board of Directors granted stock ...

Novan Inc. NOVN shares are trading higher Friday after the company reported that B-SIMPLE4 pivotal Phase 3 trial of SB206 achieved significance for the primary endpoint with no adverse events. The ...

Shares of Novan Inc. rocketed 65% in premarket trade Wednesday, after the drugmaker announced positive results of a Phase 2 trial of its skin and nails treatment. Novan is developing an antifungal gel ...

DURHAM, N.C., March 14, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (NOVN), today announced that it has entered into definitive agreements for the issuance and sale in a registered direct offering of an ...

MORRISVILLE – Biotech firm Novan, its stock mired below $1, has received permission from the Nasdaq to move its listing to the Nasdaq Capital Market and is mulling a possible reverse stock split as a ...

DURHAM – Investors reacted negatively to news of a reverse 10-for-1 split in biotech company Novan’s stock early Tuesday. Shares (nasdaq: NOVN) plunged more than 30% to 47 cents from Monday’s close of ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Weeks after a Triangle drugmaker faced a stock drop after ...

DURHAM, N.C., May 25, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it has filed a Certificate of Amendment to the Restated Certificate of ...

MORRISVILLE, N.C., June 01, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today reported that the Compensation Committee of Novan’s Board of Directors granted stock ...